Global Constipation Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 160922
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare

Constipation is common disease which is estimated to affect each individual once in life time. According to international as well regional guidelines it is characterized by frequency and nature of bowel movement. Less than 2 bowel movements per week, associated with hard stool and strain in passing is termed as constipation. Constipation may be occasional which lasts for few weeks or may be chronic which lasts for longer period and is recurrent. It may be associated with other conditions such as irritable bowel syndrome or opioid consumption.

Scope of the Report:

Based on disease type, the global constipation treatment market is segmented into chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C) and opioid induced constipation (OIC). High prevalence of chronic constipation is estimated to contribute for dominating share of CIC segment in global market while increasing opioid consumption is projected to propel for exponential growth of OIC segment during forecast period.

The global Constipation market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Constipation.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Constipation market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Constipation market by product type and applications/end industries.

Market Segment by Companies, this report covers

Takeda Pharmaceutical

Synergy Pharmaceuticals

Sucampo Pharmaceuticals

Ironwood Pharmaceuticals

Bausch Health

Abbott

AstraZeneca

Cosmo Pharmaceuticals

Sanofi

Daewoong Pharmaceuticals

Bayer

Prestige Brands Holdings

Janssen Pharmaceutical

Shionogi

Albireo Pharma

Renexxion

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Chronic Idiopathic Constipation (CIC)

Irritable Bowel Syndrome With Constipation (IBS-C)

Opioid-Induced Constipation (OIC)

Market Segment by Applications, can be divided into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Constipation Market Overview

1.1 Product Overview and Scope of Constipation

1.2 Classification of Constipation by Types

1.2.1 Global Constipation Revenue Comparison by Types (2017-2023)

1.2.2 Global Constipation Revenue Market Share by Types in 2017

1.2.3 Chronic Idiopathic Constipation (CIC)

1.2.4 Irritable Bowel Syndrome With Constipation (IBS-C)

1.2.5 Opioid-Induced Constipation (OIC)

1.3 Global Constipation Market by Application

1.3.1 Global Constipation Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Constipation Market by Regions

1.4.1 Global Constipation Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Constipation Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Constipation Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Constipation Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Constipation Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Constipation Status and Prospect (2013-2023)

1.5 Global Market Size of Constipation (2013-2023)

2 Manufacturers Profiles

2.1 Takeda Pharmaceutical

2.1.1 Business Overview

2.1.2 Constipation Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Takeda Pharmaceutical Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.2 Synergy Pharmaceuticals

2.2.1 Business Overview

2.2.2 Constipation Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Synergy Pharmaceuticals Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sucampo Pharmaceuticals

2.3.1 Business Overview

2.3.2 Constipation Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sucampo Pharmaceuticals Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.4 Ironwood Pharmaceuticals

2.4.1 Business Overview

2.4.2 Constipation Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Ironwood Pharmaceuticals Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.5 Bausch Health

2.5.1 Business Overview

2.5.2 Constipation Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Bausch Health Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.6 Abbott

2.6.1 Business Overview

2.6.2 Constipation Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Abbott Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.7 AstraZeneca

2.7.1 Business Overview

2.7.2 Constipation Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 AstraZeneca Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.8 Cosmo Pharmaceuticals

2.8.1 Business Overview

2.8.2 Constipation Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Cosmo Pharmaceuticals Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.9 Sanofi

2.9.1 Business Overview

2.9.2 Constipation Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sanofi Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.10 Daewoong Pharmaceuticals

2.10.1 Business Overview

2.10.2 Constipation Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Daewoong Pharmaceuticals Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.11 Bayer

2.11.1 Business Overview

2.11.2 Constipation Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Bayer Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.12 Prestige Brands Holdings

2.12.1 Business Overview

2.12.2 Constipation Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Prestige Brands Holdings Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.13 Janssen Pharmaceutical

2.13.1 Business Overview

2.13.2 Constipation Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Janssen Pharmaceutical Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.14 Shionogi

2.14.1 Business Overview

2.14.2 Constipation Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Shionogi Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.15 Albireo Pharma

2.15.1 Business Overview

2.15.2 Constipation Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Albireo Pharma Constipation Revenue, Gross Margin and Market Share (2016-2017)

2.16 Renexxion

2.16.1 Business Overview

2.16.2 Constipation Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Renexxion Constipation Revenue, Gross Margin and Market Share (2016-2017)

3 Global Constipation Market Competition, by Players

3.1 Global Constipation Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Constipation Players Market Share

3.2.2 Top 10 Constipation Players Market Share

3.3 Market Competition Trend

4 Global Constipation Market Size by Regions

4.1 Global Constipation Revenue and Market Share by Regions

4.2 North America Constipation Revenue and Growth Rate (2013-2018)

4.3 Europe Constipation Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Constipation Revenue and Growth Rate (2013-2018)

4.5 South America Constipation Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Constipation Revenue and Growth Rate (2013-2018)

5 North America Constipation Revenue by Countries

5.1 North America Constipation Revenue by Countries (2013-2018)

5.2 USA Constipation Revenue and Growth Rate (2013-2018)

5.3 Canada Constipation Revenue and Growth Rate (2013-2018)

5.4 Mexico Constipation Revenue and Growth Rate (2013-2018)

6 Europe Constipation Revenue by Countries

6.1 Europe Constipation Revenue by Countries (2013-2018)

6.2 Germany Constipation Revenue and Growth Rate (2013-2018)

6.3 UK Constipation Revenue and Growth Rate (2013-2018)

6.4 France Constipation Revenue and Growth Rate (2013-2018)

6.5 Russia Constipation Revenue and Growth Rate (2013-2018)

6.6 Italy Constipation Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Constipation Revenue by Countries

7.1 Asia-Pacific Constipation Revenue by Countries (2013-2018)

7.2 China Constipation Revenue and Growth Rate (2013-2018)

7.3 Japan Constipation Revenue and Growth Rate (2013-2018)

7.4 Korea Constipation Revenue and Growth Rate (2013-2018)

7.5 India Constipation Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Constipation Revenue and Growth Rate (2013-2018)

8 South America Constipation Revenue by Countries

8.1 South America Constipation Revenue by Countries (2013-2018)

8.2 Brazil Constipation Revenue and Growth Rate (2013-2018)

8.3 Argentina Constipation Revenue and Growth Rate (2013-2018)

8.4 Colombia Constipation Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Constipation by Countries

9.1 Middle East and Africa Constipation Revenue by Countries (2013-2018)

9.2 Saudi Arabia Constipation Revenue and Growth Rate (2013-2018)

9.3 UAE Constipation Revenue and Growth Rate (2013-2018)

9.4 Egypt Constipation Revenue and Growth Rate (2013-2018)

9.5 Nigeria Constipation Revenue and Growth Rate (2013-2018)

9.6 South Africa Constipation Revenue and Growth Rate (2013-2018)

10 Global Constipation Market Segment by Type

10.1 Global Constipation Revenue and Market Share by Type (2013-2018)

10.2 Global Constipation Market Forecast by Type (2018-2023)

10.3 Chronic Idiopathic Constipation (CIC) Revenue Growth Rate (2013-2023)

10.4 Irritable Bowel Syndrome With Constipation (IBS-C) Revenue Growth Rate (2013-2023)

10.5 Opioid-Induced Constipation (OIC) Revenue Growth Rate (2013-2023)

11 Global Constipation Market Segment by Application

11.1 Global Constipation Revenue Market Share by Application (2013-2018)

11.2 Constipation Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacies Revenue Growth (2013-2018)

11.4 Retail Pharmacies Revenue Growth (2013-2018)

11.5 Online Pharmacies Revenue Growth (2013-2018)

12 Global Constipation Market Size Forecast (2018-2023)

12.1 Global Constipation Market Size Forecast (2018-2023)

12.2 Global Constipation Market Forecast by Regions (2018-2023)

12.3 North America Constipation Revenue Market Forecast (2018-2023)

12.4 Europe Constipation Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Constipation Revenue Market Forecast (2018-2023)

12.6 South America Constipation Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Constipation Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Constipation Picture

Table Product Specifications of Constipation

Table Global Constipation and Revenue (Million USD) Market Split by Product Type

Figur

Please fill the form below, to recieve the report sample


+1